New reports have demonstrated that certain skin-cancer treatments which target specific genes are yielding extraordinary results. According to Hal Barron, chief medical officer of Roche, the findings “mark a major step forward in personalizing the treatment of metastic melanoma.” Said another doctor of the results, “[it] takes your breath away if you’re a melanoma doc.”
Today, it is skin cancer. Tomorrow, it’ll be lung and breast cancer. I have said it before and I’ll say it again, the future of personalized medicine is accelerating.
Related Posts by Healthcare futurist Jack Uldrich: